InvestSMART

Mayne Pharma Group Limited (ASX: MYX) - Announcements

Current share price for MYX : $2.500 0.13 (4.94%)+

ASX company news and announcements for Mayne Pharma Group Limited (MYX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mayne Pharma Group Limited (MYX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mayne Pharma Group Limited (MYX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mayne Pharma Group Limited (MYX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$205 Preliminary Final Report 25 Aug 2017 9:37AM $0.710 $2.500 risen by 252.11%
$205 Ceasing to be a substantial holder from CBA 16 Aug 2017 3:36PM $0.763 $2.500 risen by 227.87%
$205 Change in substantial holding from CBA 14 Aug 2017 12:12AM $0.775 $2.500 risen by 222.58%
$205 Change in substantial holding 8 Aug 2017 6:29PM $0.805 $2.500 risen by 210.56%
$205 Mayne Pharma market update 8 Aug 2017 9:44AM $0.890 $2.500 risen by 180.90%
$205 Change in substantial holding from CBA 31 Jul 2017 4:36PM $0.960 $2.500 risen by 160.42%
$205 Appendix 3B 14 Jul 2017 2:47PM $0.990 $2.500 risen by 152.53%
$205 Appendix 3B 27 Jun 2017 4:59PM $1.125 $2.500 risen by 122.22%
$205 Change of Director's Interest Notice 27 Jun 2017 8:28AM $1.145 $2.500 risen by 118.34%
$205 FDA approval and first generic launch of Acticlate tablets 15 Jun 2017 9:12AM $1.040 $2.500 risen by 140.38%
$205 Appendix 3B 9 Jun 2017 4:37PM $0.995 $2.500 risen by 151.26%
$205 2016 Sustainability Report 8 Jun 2017 9:34AM $1.040 $2.500 risen by 140.38%
$205 Appendix 3B 26 May 2017 2:20PM $1.095 $2.500 risen by 128.31%
$205 Change in substantial holding 24 May 2017 5:43PM $1.095 $2.500 risen by 128.31%
$205 Appendix 3B 22 May 2017 5:08PM $1.105 $2.500 risen by 126.24%
$205 Change of Director's Interest Notice 11 May 2017 8:29AM n/a $2.500 n/a
$205 Appendix 3B 8 May 2017 10:25AM $1.183 $2.500 risen by 111.42%
$205 Response to ASX Aware Letter 4 May 2017 9:22AM $1.205 $2.500 risen by 107.47%
$205 Becoming a substantial holder 3 May 2017 6:07PM $1.205 $2.500 risen by 107.47%
$205 Ceasing to be a substantial holder from CGF 3 May 2017 11:49AM $1.213 $2.500 risen by 106.19%
$205 Clarification statement 2 May 2017 10:02AM $1.205 $2.500 risen by 107.47%
$205 Investor Day - Presentation 1 May 2017 12:06AM $1.350 $2.500 risen by 85.19%
$205 Becoming a substantial holder from CGF 28 Apr 2017 1:48PM $1.323 $2.500 risen by 89.04%
$205 Mayne Pharma to host Investor Day on May 1st, 2017 26 Apr 2017 10:41AM $1.345 $2.500 risen by 85.87%
$205 Becoming a substantial holder 11 Apr 2017 2:47PM $1.393 $2.500 risen by 79.53%

701 - 725 of 910 results

Page 29 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.